TTK Healthcare Ltd Stock Price Today (NSE: TTKHLTCARE)
Fundamental Score
TTK Healthcare Ltd Share Price Live NSE/BSE & Institutional Fundamental Analysis
TTK Healthcare Ltd share price today is ₹933.85, up +0.00% on NSE/BSE as of 18 February 2026. TTK Healthcare Ltd (TTKHLTCARE) is a Small-cap company in the Diversified sector with a market capitalisation of ₹1.55K (Cr). The 52-week high for TTKHLTCARE share price is ₹N/A and the 52-week low is ₹N/A. At a P/E ratio of 22.00x, TTKHLTCARE is currently trading below its industry average P/E of 24.16x. The company has a Return on Equity (ROE) of 6.89% and a debt-to-equity ratio of 0.02.
TTK Healthcare Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
TTK Healthcare Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
TTK Healthcare Share Price: A Conservative Value Investor's Perspective
In the diversified sector, a key challenge for investors is identifying companies that consistently allocate capital effectively across diverse business lines. This analysis focuses on the TTK Healthcare share price of ₹951.2999877929688 from the viewpoint of a conservative value investor prioritizing capital safety. Our approach emphasizes a deep dive into fundamental metrics rather than short-term price movements. This analysis is part of an 80-parameter fundamental audit verified by Sweta Mishra.
A critical metric for value investors is the Price-to-Earnings (PE) ratio. TTK Healthcare's PE of 22.0 requires careful consideration in the context of its Return on Capital Employed (ROCE) of 9.26%. A ROCE of 9.26%, while positive, suggests that the company's economic moat might not be exceptionally strong compared to companies generating significantly higher returns. The lower ROCE indicates that TTK Healthcare may face challenges in reinvesting capital at high rates of return and maintaining a strong competitive advantage.
When evaluating companies in a diversified sector, management quality is paramount. While we cannot definitively assess management's capabilities without intimate knowledge, it's useful to consider peers. For instance,
Godrej Industries Ltd enjoys a reputation for strategic capital allocation within its diversified portfolio. Observing how TTK Healthcare's management allocates capital across its healthcare and consumer products segments, and comparing those decisions with peers like Godrej, can provide valuable insights.Ultimately, a ROCE of 9.26% impacts the long-term compounding potential of TTK Healthcare. While positive, it implies a slower rate of reinvestment and potential limitations in strengthening the company's moat. Our assessment of the TTK Healthcare share price necessitates further investigation into the drivers of its ROCE, its sustainability, and a thorough comparison with sector peers to determine if the current valuation reflects the underlying business quality and future growth prospects from a capital safety perspective.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
TTK Healthcare Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of TTKHLTCARE across key market metrics for learning purposes.
Positive Indicators
7 factors identified
Excellent EPS Growth (41.96% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (41.96% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Conservative Debt Levels (D/E: 0.02)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (27.77x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Strong Cash Generation (₹91.86 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Balanced Promoter Holding (74.56%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
5 factors identified
Below-Average Return on Equity (6.89%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (9.26%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Margin Pressure Concerns (4.32%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
Limited Growth History (4.42% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.
Limited Institutional Interest (FII+DII: 3.08%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
TTK Healthcare Ltd Financial Statements
Comprehensive financial data for TTK Healthcare Ltd including income statement, balance sheet and cash flow
About TTKHLTCARE (TTK Healthcare Ltd)
TTK Healthcare Ltd (TTKHLTCARE) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Diversified sector with a current market capitalisation of ₹1.55K (Cr). TTK Healthcare Ltd has delivered a Return on Equity (ROE) of 6.89% and a ROCE of 9.26%. The debt-to-equity ratio stands at 0.02, reflecting the company's capital structure. Investors tracking TTKHLTCARE share price can monitor key metrics including P/E ratio, promoter holding of 74.56%, and quarterly earnings growth.
Company Details
Key Leadership
Corporate Events
TTKHLTCARE Share Price: Frequently Asked Questions
What is the current share price of TTK Healthcare Ltd (TTKHLTCARE)?
As of 18 Feb 2026, 10:38 am IST, TTK Healthcare Ltd share price is ₹933.85. The TTKHLTCARE stock has a market capitalisation of ₹1.55K (Cr) on NSE/BSE.
Is TTKHLTCARE share price Overvalued or Undervalued?
TTKHLTCARE share price is currently trading at a P/E ratio of 22.00x, compared to the industry average of 24.16x. Based on this relative valuation, the TTK Healthcare Ltd stock appears to be Undervalued against its sector peers.
What is the 52-week high and low of TTKHLTCARE share price?
The 52-week high of TTKHLTCARE share price is ₹N/A and the 52-week low is ₹N/A.
What factors affect the TTK Healthcare Ltd share price?
Key factors influencing TTKHLTCARE share price include quarterly earnings growth (Sales Growth: 2.56%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is TTK Healthcare Ltd a good stock for long-term investment?
TTK Healthcare Ltd shows a 5-year Profit Growth of 41.96% and an ROE of 6.89%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.02 before investing in TTKHLTCARE shares.
How does TTK Healthcare Ltd compare with its industry peers?
TTK Healthcare Ltd competes with major peers in the Diversified. Investors should compare TTKHLTCARE share price P/E of 22.00x and ROE of 6.89% against the industry averages to determine competitive standing.
What is the P/E ratio of TTKHLTCARE and what does it mean?
TTKHLTCARE share price has a P/E ratio of 22.00x compared to the industry average of 24.16x. Investors pay ₹22 for every ₹1 of annual earnings.
How is TTKHLTCARE performing according to Bull Run's analysis?
TTKHLTCARE has a Bull Run fundamental score of 50.7/100, indicating moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does TTKHLTCARE belong to?
TTKHLTCARE operates in the Diversified industry. This classification helps understand the competitive landscape and sector-specific trends affecting TTK Healthcare Ltd share price.
What is Return on Equity (ROE) and why is it important for TTKHLTCARE?
TTKHLTCARE has an ROE of 6.89%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently TTK Healthcare Ltd generates profits from shareholders capital.
How is TTKHLTCARE debt-to-equity ratio and what does it indicate?
TTKHLTCARE has a debt-to-equity ratio of 0.02, which indicates conservative financing with low financial risk.
What is TTKHLTCARE dividend yield and is it a good dividend stock?
TTKHLTCARE offers a dividend yield of 0.91%, meaning you receive ₹0.91 annual dividend for every ₹100 invested in TTK Healthcare Ltd shares.
How has TTKHLTCARE share price grown over the past 5 years?
TTKHLTCARE has achieved 5-year growth rates of: Sales Growth 4.42%, Profit Growth 41.96%, and EPS Growth 41.96%.
What is the promoter holding in TTKHLTCARE and why does it matter?
Promoters hold 74.56% of TTKHLTCARE shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in TTK Healthcare Ltd.
What is TTKHLTCARE market capitalisation category?
TTKHLTCARE has a market capitalisation of ₹1554 crores, placing it in the Small-cap category.
How volatile is TTKHLTCARE stock?
TTKHLTCARE has a beta of N/A. A beta > 1 suggests the TTK Healthcare Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is TTKHLTCARE operating profit margin trend?
TTKHLTCARE has a 5-year average Operating Profit Margin (OPM) of 4.32%, indicating the company's operational efficiency.
How is TTKHLTCARE quarterly performance?
Recent quarterly performance shows TTK Healthcare Ltd YoY Sales Growth of 2.56% and YoY Profit Growth of 18.55%.
What is the institutional holding pattern in TTKHLTCARE?
TTKHLTCARE has FII holding of 1.90% and DII holding of 1.18%. Significant institutional holding often suggests professional confidence in the TTK Healthcare Ltd stock.